Početna › Amiloidoza › Oregon
Kliničke studije za Amiloidoza u državi Oregon
6 studija za Amiloidoza traži sudionike na lokacijama u državi Oregon.
Gradovi u državi Oregon
Službeni tekst studije (engleski)
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
- Research Site, Portland
U tijeku regrutacijaOpažajna studija
Od 18 do 130 godina · Oba spola · Ažurirano 23. ruj 2026. · NCT06465810TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Clinical Trial Site, Portland
U tijeku regrutacijaFaza 3
Od 18 do 85 godina · Oba spola · Ažurirano 16. ruj 2026. · NCT07052903Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Oregon Health & Science University, Portland
U tijeku regrutacijaFaza 3
Od 18 do 75 godina · Oba spola · Ažurirano 4. kol 2026. · NCT06563895A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion
- Oregon Medical Research Center /ID# 255119, Portland
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 13. svi 2026. · NCT06158854Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic Amyloidosis
- Oregon Health & Science University, Portland
U tijeku regrutacijaFaza 2
Od 40 do 90 godina · Oba spola · Ažurirano 13. tra 2026. · NCT05758493MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
- Oregon Health and Science University (OHSU), Portland
U tijeku regrutacijaFaza 3
Od 18 do 90 godina · Oba spola · Ažurirano 27. ožu 2026. · NCT06128629Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.